IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer

Yongchao Liu, Jing Zhao, Wenhong Zhang, Jun Gan, Chengen Hu, Guangjian Huang, Ying Zhang

Research output: Contribution to journal › Article

Abstract

Long non-coding RNAs (IncRNAs), which have evolved as important gene expression modulators, are involved in human malignancies. The down-regulation of IncRNA growth arrest specific transcript 5 (GAS5) has been reported in several cancers, however, the underlying mechanism of IncRNA GAS5 in stomach cancer is poorly understood. In this study, we found that IncRNA GAS5 had lower expression in stomach cancer tissues than the normal counterparts. IncRNA GAS5 was shown to interact with Y-box binding protein 1 (YBX1), and IncRNA GAS5 knockdown was shown to accelerate YBX1 protein turnover without affecting YBX1 transcription. IncRNA GAS5 down-regulation reduced the YBX1 protein level, which decreased YBX1-transactivated p21 expression and abolished G1 phase cell cycle arrest in stomach cancer. These results delineate a novel mechanism of IncRNA GAS5 in suppressing stomach carcinogenesis, and the IncRNA GAS5/YBX1/p21 pathway we discovered may provide useful targets for developing IncRNA-based therapies for stomach cancer.

Original languageEnglish (US)
Article number10159
JournalScientific Reports
Volume5
DOIs
StatePublished - May 11 2015

Fingerprint

Y-Box-Binding Protein 1
G1 Phase Cell Cycle Checkpoints
Stomach Neoplasms
Down-Regulation
Long Noncoding RNA
growth arrest specific transcript 5
G1 Phase
Neoplasms
Stomach
Carcinogenesis
Proteins

ASJC Scopus subject areas

  • General

Cite this

IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. / Liu, Yongchao; Zhao, Jing; Zhang, Wenhong; Gan, Jun; Hu, Chengen; Huang, Guangjian; Zhang, Ying.

In: Scientific Reports, Vol. 5, 10159, 11.05.2015.

Research output: Contribution to journal › Article

Liu, Y, Zhao, J, Zhang, W, Gan, J, Hu, C, Huang, G & Zhang, Y 2015, 'IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer', Scientific Reports, vol. 5, 10159. https://doi.org/10.1038/srep10159
Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G et al. IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Scientific Reports. 2015 May 11;5. 10159. https://doi.org/10.1038/srep10159
Liu, Yongchao ; Zhao, Jing ; Zhang, Wenhong ; Gan, Jun ; Hu, Chengen ; Huang, Guangjian ; Zhang, Ying. / IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. In: Scientific Reports. 2015 ; Vol. 5.
@article{624239da0d524bb68c8d5d9b6aedd27a,
title = "IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer",
abstract = "Long non-coding RNAs (IncRNAs), which have evolved as important gene expression modulators, are involved in human malignancies. The down-regulation of IncRNA growth arrest specific transcript 5 (GAS5) has been reported in several cancers, however, the underlying mechanism of IncRNA GAS5 in stomach cancer is poorly understood. In this study, we found that IncRNA GAS5 had lower expression in stomach cancer tissues than the normal counterparts. IncRNA GAS5 was shown to interact with Y-box binding protein 1 (YBX1), and IncRNA GAS5 knockdown was shown to accelerate YBX1 protein turnover without affecting YBX1 transcription. IncRNA GAS5 down-regulation reduced the YBX1 protein level, which decreased YBX1-transactivated p21 expression and abolished G1 phase cell cycle arrest in stomach cancer. These results delineate a novel mechanism of IncRNA GAS5 in suppressing stomach carcinogenesis, and the IncRNA GAS5/YBX1/p21 pathway we discovered may provide useful targets for developing IncRNA-based therapies for stomach cancer.",
author = "Yongchao Liu and Jing Zhao and Wenhong Zhang and Jun Gan and Chengen Hu and Guangjian Huang and Ying Zhang",
year = "2015",
month = "5",
day = "11",
doi = "10.1038/srep10159",
language = "English (US)",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - IncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer

AU - Liu, Yongchao

AU - Zhao, Jing

AU - Zhang, Wenhong

AU - Gan, Jun

AU - Hu, Chengen

AU - Huang, Guangjian

AU - Zhang, Ying

PY - 2015/5/11

Y1 - 2015/5/11

N2 - Long non-coding RNAs (IncRNAs), which have evolved as important gene expression modulators, are involved in human malignancies. The down-regulation of IncRNA growth arrest specific transcript 5 (GAS5) has been reported in several cancers, however, the underlying mechanism of IncRNA GAS5 in stomach cancer is poorly understood. In this study, we found that IncRNA GAS5 had lower expression in stomach cancer tissues than the normal counterparts. IncRNA GAS5 was shown to interact with Y-box binding protein 1 (YBX1), and IncRNA GAS5 knockdown was shown to accelerate YBX1 protein turnover without affecting YBX1 transcription. IncRNA GAS5 down-regulation reduced the YBX1 protein level, which decreased YBX1-transactivated p21 expression and abolished G1 phase cell cycle arrest in stomach cancer. These results delineate a novel mechanism of IncRNA GAS5 in suppressing stomach carcinogenesis, and the IncRNA GAS5/YBX1/p21 pathway we discovered may provide useful targets for developing IncRNA-based therapies for stomach cancer.

AB - Long non-coding RNAs (IncRNAs), which have evolved as important gene expression modulators, are involved in human malignancies. The down-regulation of IncRNA growth arrest specific transcript 5 (GAS5) has been reported in several cancers, however, the underlying mechanism of IncRNA GAS5 in stomach cancer is poorly understood. In this study, we found that IncRNA GAS5 had lower expression in stomach cancer tissues than the normal counterparts. IncRNA GAS5 was shown to interact with Y-box binding protein 1 (YBX1), and IncRNA GAS5 knockdown was shown to accelerate YBX1 protein turnover without affecting YBX1 transcription. IncRNA GAS5 down-regulation reduced the YBX1 protein level, which decreased YBX1-transactivated p21 expression and abolished G1 phase cell cycle arrest in stomach cancer. These results delineate a novel mechanism of IncRNA GAS5 in suppressing stomach carcinogenesis, and the IncRNA GAS5/YBX1/p21 pathway we discovered may provide useful targets for developing IncRNA-based therapies for stomach cancer.

UR - http://www.scopus.com/inward/record.url?scp=84929159456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929159456&partnerID=8YFLogxK

U2 - 10.1038/srep10159

DO - 10.1038/srep10159

M3 - Article

C2 - 25959498

AN - SCOPUS:84929159456

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 10159

ER -

Access to Document